Skip to content
About
About us
Our Capabilities
Our Facility
Our Team
Work at IDT
Advanced Therapies
Aseptic Fill & Finish
mRNA – ADCs
Specialty Orals
Psychedelics/Medicinal Cannabis
Oral Finished Dose
API & Intermediates
Active Pharmaceutical Ingredients
Investors
ASX Announcements
Share Price
Corporate Governance
Investor Presentations
Annual Reports
News
Contact
News
Home
»
News
»
IDT 2019 Annual Report
IDT 2019 Annual Report
August 29, 2019
|
News
IDT (ASX: IDT); Has posted its 2019 Annual Report.
The report can be read
here
.
Posts navigation
← FDA revises IDT’s Facility Inspection Classification
IDT – Medicinal Cannabis Strategic Update →
